This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 3 CIPO patents and 1 EPO patent. Top assignees: Arbutus Biopharma Corporation, Genevant Sciences Gmbh. Active years: 2021-2026.
Company Filing History:
Years Active: 2021-2026
Title: Kieu Mong Lam: Innovator in Lipid Conjugates
Introduction
Kieu Mong Lam is a notable inventor based in Burnaby, Canada. She has made significant contributions to the field of biopharmaceuticals, particularly in the development of PEG-conjugated lipids. Her work focuses on innovations that enhance the delivery of nucleic acids through lipid nanoparticles.
Latest Patents
Kieu Mong Lam holds a patent for "Negatively Charged Peg-Lipid Conjugates." This invention provides PEG-conjugated lipids of formula (I): A-B-C (I), wherein A, B, and C have specific values defined in the specification. The patent also includes compositions comprising these PEG-conjugated lipids, nucleic acid lipid nanoparticles, and methods for their use.
Career Highlights
Kieu Mong Lam is currently employed at Arbutus Biopharma Corporation, where she continues to advance her research in lipid conjugates. Her innovative work is aimed at improving therapeutic delivery systems, which is crucial in the biopharmaceutical industry.
Collaborations
Some of her notable coworkers include James Heyes and Mark Wood, who collaborate with her on various projects within the company.
Conclusion
Kieu Mong Lam is a pioneering inventor whose work in PEG-conjugated lipids is shaping the future of biopharmaceuticals. Her contributions are vital for the advancement of effective drug delivery systems.